Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (125)
- Compliance and enforcement (33)
- Import and export (30)
- Shortages and supply disruptions (16)
- Sunscreens (9)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1291 result(s) found, displaying 801 to 825
-
Safety alertsTo date, the CORE HIV Rapid Test has NOT been registered or included in the ARTG, and there is a risk that the test may not perform as intended or may risk the health and safety of the user.
-
-
Safety alerts
-
Market actionsGlobal Orthopaedic Technology is issuing a hazard alert for the MSA Hip System due to it having a higher-than-expected revision rate.
-
Market actionsRecall due to potential for delay to treatment in rare cases.
-
Market actionsConsumers and health professionals are advised that Roche Diagnostic Australia, in consultation with the TGA, is undertaking a recall for product correction of its Accu-Chek Mobile blood glucose meter due to the potential for incorrect blood glucose readings as a result of users not following the device instructions.
-
-
Market actionsThe TGA has suspended the Cereform silicone gel-filled breast implants and associated sizers from the Australian Register of Therapeutic Goods.
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Market actionsInvacare Australia, in consultation with the TGA, is undertaking a recall for product correction of some units of its Aquatec Ocean VIP mobile shower and toilet commode.
-
Market actionsRecall due to potential for connection issues.
-
Safety alerts
-
Safety alertsAs a precaution, health professionals are advised to avoid using all sizes and batches of AFT-distributed Provive and Sandoz Propofol 1% products until further investigation is complete.
-
Safety alertsSafety alert due to potential for incorrect INR results.
-
Safety alerts
-
Safety alerts
-